MiR-502 Suppresses TNF- α-Induced Nucleus Pulposus Cell Apoptosis by Targeting TARF2

Biomed Res Int. 2021 Apr 1:2021:5558369. doi: 10.1155/2021/5558369. eCollection 2021.

Abstract

Intervertebral disc degeneration (IVDD) is a common cause of low back pain. This study is aimed at investigating the role of microRNAs (miRNAs) in regulating human nucleus pulposus (NP) cell injury induced by tumor necrosis factor- (TNF-) α in IVDD. In this study, we induced NP cells with 20 ng/mL TNF-α in vitro, which promoted the obvious apoptosis of NP cells and the activation of nuclear transcription factor (NF)-κB. In contrast, using the specific NF-κB inhibitor BAY 11-7082 to treat cells greatly impaired the activation of NF-κB and increased the sensitivity of NP cells to TNF-α-induced apoptosis. Moreover, both TNF-α and BAY 11-7082 treatments were associated with marked miRNA dysregulation, with miR-502 being upregulated by TNF-α treatment and downregulated by BAY 11-7082 treatment, respectively. And the overexpression of miR-502 enhanced NF-κB activation and suppressed apoptosis of human NP cells induced by TNF-α, whereas the opposite was observed following miR-502 inhibition. Last, through bioinformatic analyses and luciferase reporter gene experiments, we identified TRAF2, an important activator of NF-κB, as a miR-502 target gene. Similarly, siRNA-mediated knockdown of the TRAF2 expression also suppressed TNF-α-induced apoptosis and enhanced NF-κB activation. Our findings provide evidence indicating that miR-502 is a key regulator of apoptosis of human NP cells induced by TNF-α by targeting TRAF2 and activating NF-κB.

Publication types

  • Retracted Publication

MeSH terms

  • Apoptosis* / drug effects
  • Apoptosis* / genetics
  • Base Sequence
  • Gene Knockdown Techniques
  • Humans
  • Intervertebral Disc Degeneration / genetics
  • Intervertebral Disc Degeneration / pathology
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • Nucleus Pulposus / pathology*
  • TNF Receptor-Associated Factor 2 / genetics
  • TNF Receptor-Associated Factor 2 / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • MIRN502 microRNA, human
  • MicroRNAs
  • NF-kappa B
  • TNF Receptor-Associated Factor 2
  • Tumor Necrosis Factor-alpha